DocGo (DCGO) Expected to Announce Quarterly Earnings on Thursday

Key Points

• DocGo (DCGO) is set to release its Q2 2025 earnings report on Thursday, August 7th, with expected earnings of ($0.06) per share and revenues of $77.58 million.
• The company recently reported a EPS of ($0.09) for the previous quarter, missing expectations and generating a revenue of $96.03 million, lower than analyst estimates.
• Despite recent downgrades by analysts, DocGo holds a "Moderate Buy" rating with an average price target of $3.56; notable investors have increased their stakes in the company.

DocGo (NASDAQ:DCGO - Get Free Report) will likely be issuing its Q2 2025 quarterly earnings data after the market closes on Thursday, August 7th. Analysts expect DocGo to post earnings of ($0.06) per share and revenue of $77.58 million for the quarter. DocGo has set its FY 2025 guidance at EPS.

DocGo (NASDAQ:DCGO - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The firm had revenue of $96.03 million during the quarter, compared to the consensus estimate of $104.25 million. DocGo had a negative net margin of 0.12% and a positive return on equity of 2.52%. On average, analysts expect DocGo to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

DocGo Stock Down 2.2%

Shares of NASDAQ:DCGO traded down $0.03 during midday trading on Friday, hitting $1.33. The stock had a trading volume of 568,763 shares, compared to its average volume of 881,938. The company's 50-day moving average price is $1.50 and its 200-day moving average price is $2.63. The company has a market capitalization of $135.63 million, a P/E ratio of -66.50 and a beta of 0.97. DocGo has a fifty-two week low of $1.23 and a fifty-two week high of $5.68.

Institutional Trading of DocGo

Several institutional investors have recently modified their holdings of the business. AQR Capital Management LLC raised its position in shares of DocGo by 219.1% during the first quarter. AQR Capital Management LLC now owns 476,645 shares of the company's stock worth $1,258,000 after acquiring an additional 327,269 shares during the last quarter. Acadian Asset Management LLC bought a new position in shares of DocGo in the 1st quarter worth about $338,000. Jane Street Group LLC raised its position in shares of DocGo by 18.8% in the 1st quarter. Jane Street Group LLC now owns 85,442 shares of the company's stock worth $226,000 after acquiring an additional 13,505 shares in the last quarter. Finally, Strs Ohio bought a new position in shares of DocGo in the 1st quarter worth about $76,000. Institutional investors own 56.44% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Canaccord Genuity Group reaffirmed a "hold" rating and issued a $1.45 target price (down previously from $5.00) on shares of DocGo in a report on Monday, May 12th. Needham & Company LLC reduced their target price on DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Finally, BTIG Research downgraded DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $3.56.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.